AMINOSYN II WITH ELECTROLYTES IN DEXTROSE INJECTION WITH CALCIUM SOLUTION

Valsts: Kanāda

Valoda: angļu

Klimata pārmaiņas: Health Canada

Aktīvā sastāvdaļa:

ACETYL-L-TYROSINE; DEXTROSE; SODIUM CHLORIDE; POTASSIUM CHLORIDE; MAGNESIUM CHLORIDE; CALCIUM CHLORIDE; POTASSIUM PHOSPHATE DIBASIC; L-ISOLEUCINE; SERINE; L-LEUCINE; LYSINE (LYSINE ACETATE); METHIONINE; L-PHENYLALANINE; L-THREONINE; TRYPTOPHAN; L-VALINE; L-ALANINE; L-ARGININE; L-ASPARTIC ACID; GLUTAMIC ACID; GLYCINE; HISTIDINE; L-PROLINE

Pieejams no:

HOSPIRA HEALTHCARE ULC

ATĶ kods:

B05BA10

SNN (starptautisko nepatentēto nosaukumu):

COMBINATIONS

Deva:

115MG; 20G; 205MG; 22MG; 51MG; 37MG; 261MG; 280MG; 225MG; 425MG; 446MG; 73MG; 126MG; 170MG; 85MG; 212MG; 422MG; 432MG; 298MG; 314MG; 212MG; 128MG; 307MG

Zāļu forma:

SOLUTION

Kompozīcija:

ACETYL-L-TYROSINE 115MG; DEXTROSE 20G; SODIUM CHLORIDE 205MG; POTASSIUM CHLORIDE 22MG; MAGNESIUM CHLORIDE 51MG; CALCIUM CHLORIDE 37MG; POTASSIUM PHOSPHATE DIBASIC 261MG; L-ISOLEUCINE 280MG; SERINE 225MG; L-LEUCINE 425MG; LYSINE (LYSINE ACETATE) 446MG; METHIONINE 73MG; L-PHENYLALANINE 126MG; L-THREONINE 170MG; TRYPTOPHAN 85MG; L-VALINE 212MG; L-ALANINE 422MG; L-ARGININE 432MG; L-ASPARTIC ACID 298MG; GLUTAMIC ACID 314MG; GLYCINE 212MG; HISTIDINE 128MG; L-PROLINE 307MG

Ievadīšanas:

INTRAVENOUS

Vienības iepakojumā:

1000ML

Receptes veids:

Ethical

Ārstniecības joma:

CALORIC AGENTS

Produktu pārskats:

Active ingredient group (AIG) number: 2350882002; AHFS:

Autorizācija statuss:

CANCELLED POST MARKET

Autorizācija datums:

2012-08-03

Produkta apraksts

PRESCRIBING INFORMATION
AMINOSYN® II IN DEXTROSE INJECTION
AMINOSYN® II WITH ELECTROLYTES IN DEXTROSE INJECTION
AMINOSYN® II WITH ELECTROLYTES IN DEXTROSE INJECTION
WITH CALCIUM
NUTRIMIX® DUAL CHAMBER CONTAINERS
Nutritive with and without Electrolyte Supplements for Intravenous
Infusion
Hospira Healthcare Corporation
DATE OF PREPARATION:
5400 Côte-de-Liesse
May 28, 2004
Town of Mount Royal (QC), CANADA
H4P 1A5
Control#: 091791, 091794, 091796, 091797, 091802, 091806
- 2 -
PRESCRIBING INFORMATION
NAME OF DRUGS
AMINOSYN® II IN DEXTROSE INJECTION
AMINOSYN® II WITH ELECTROLYTES IN DEXTROSE INJECTION
AMINOSYN® II WITH ELECTROLYTES IN DEXTROSE INJECTION
WITH CALCIUM
NUTRIMIX® DUAL CHAMBER CONTAINERS
THERAPEUTIC OR PHARMACOLOGICAL CLASSIFICATION
Nutritive with and without Electrolyte Supplements for Intravenous
Infusion
CLINICAL PHARMACOLOGY
Total parenteral nutrition consists of appropriate amino acids,
electrolytes, trace metals, vitamins
and an energy source. This may be accomplished by administering
AMINOSYN® II (amino acids)
with or without electrolytes, fat emulsion plus concentrated dextrose,
vitamins and trace metals.
AMINOSYN® II (an amino acid injection) with or without Electrolytes
in Dextrose Injection with or
without Calcium obtained after thoroughly mixing the contents of the
two chambers provides
carbohydrate calories and amino acids to promote protein synthesis and
wound healing, to reduce
the rate of endogenous protein catabolism and to minimize liver
glycogen depletion.
INDICATIONS AND CLINICAL USES
1. PERIPHERAL VEIN ADMINISTRATION
AMINOSYN® II 3.5% in 5% Dextrose Injection and AMINOSYN® II 3.5% M
(amino acid injection
3.5% with maintenance electrolytes) in 5% Dextrose Injection are
indicated for peripheral vein
infusion as a source of nitrogen in the intravenous treatment of acute
surgical patients with
adequate store of body fat, in whom, for short periods of time, oral
nutrition cannot be tolerated or
is not desirable. In such instances, the patients' energy needs are
met from their ow